The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I understand the frustration with the SP in this share. My summary would be:
- Lots of encouraging updates and tie ups with large companies.
- Richard Griffiths a large shareholder has been selling, down from a 15% stake to a 5% stake, so nearly all out.
- If he hadn't been selling, supply and demand tells us this share would be tracking upwards, encouraging it has stayed stable despite him selling 10% of the company.
- Unlike other shares, they are lots of reasons to be confident, it will require patience and once RG has finished selling it will rise as other institutions are buying in.
May take a number of months but very encouraged that this will break through 2.8p and head upwards.
What does it take to make this grow ?? Lots of innovation and unique position but for months n months its been stagnant and depressed . I’ve just kept this as bottom drawer, but it does warm you to know they are expanding , so as the other poster says keep adding and your long standing patience will eventually be rewarded. Let’s hope we can get above 5p soon. Good luck all
Could be impacted by the Deepverge update earlier in week. Just a thought. It's a shame as I said to myself only yesterday I was pleased with how DMTR was holding its SP steady. Guess I shouldn't have thunk it!
Bradley. We will be alright. No brainier investment imop.
OB. I notice the BOE keep changing their economic outlook. Warren Buffet is raising concerns over inflation, interested times ahead.
All the best.
USP: DMTR ! When AZ can't spare engineers to stir the soup you know the industry is looking for change !!! Deepmatters formula is similar to that of Reed Elsevier in the late 90s when they split huge tomes into bite size formula and sold it to chemists .... A £250 book now worth £500k overnight !
Evening bradders
You were very smart buying this stock IMO, have a read through all the RNS to make you feel better...
Chill chap :)
I thought I was being smart by buying this stock ?
Is not a true indicator of DMTR prospects as the management team currently have 7 vacancies posted all suggesting growth ; finance , stack developer and analysts ! Add a few and add some patience